×

UPSC Courses

DNA banner

DAILY NEWS ANALYSIS

GS-II :
  • 21 February, 2020

  • 3 Min Read

Govt. to revive old drug manufacturing units

Syllabus subtopic:

  • Issues Relating to Development and Management of Social Sector/Services relating to Health, Education, Human Resources.
  • Government Policies and Interventions for Development in various sectors and Issues arising out of their Design and Implementation

Prelims and Mains focus: about the move and its significance; about Coronavirus outbreak and its impact on India-China trade; about CDSCO

News: The government is planning to revive old drug manufacturing units that produced key ingredients for crucial medicines in the past, but are now being imported from China.

Background

  • The move is significant in the backdrop of the novel coronavirus (COVID-19) outbreak in China, and disruption of global supply chains.

  • China contributes to almost 70 per cent of India’s imports of key ingredients for medicines.

About the move

  • In response to the novel coronavirus outbreak, the Department of Pharmaceuticals constituted a committee under the chairmanship of Central Drugs Standard Control Organisation (CDSCO) Joint Drug Controller to assess and “closely monitor” the situation.

  • The committee has identified 58 active pharmaceutical ingredients (APIs), intermediates and key starting materials (KSMs) where India needs to build self-reliance. Considering the long gestation period to start a new plant, the government is considering whether upgrading older facilities with newer technology would help expedite the process.

  • Over the last three decades, most of the 7-8 manufacturing plants producing as many as 20 ingredients such as penicillin G, erythromycin, rifamycin, tetracycline, citric acid and vitamin B12, were shut down due to “cheaper alternatives from China”. The possibility of upgrading and restarting these plants is under consideration of the Department of Pharmaceuticals.

  • The idea is looking to wean away the Indian pharmaceutical industry from its heavy dependence on Chinese imports and strengthen its self-reliance. While India had the capability to manufacture most key ingredients, there was no domestic manufacturer currently for fermentation-based ingredients. Fermentation-based ingredients are used in most antibiotics and vitamins.

Why is government’s support necessary?

  • Unless the pharmaceutical industry is incentivised at least for a few years the way China incentivised its own pharmaceutical industry, there is little chance of private investment in this sector.

  • Three decades back, China wasn’t even in the picture in API production. But then, with full government support, they scaled up and sold to India at 20-25 percent less than domestic companies producing bulk drugs. Even with import duties, their products were cheaper, so Indian formulators began picking them over Indian manufacturers.

  • China was able to build its cost-effective active pharmaceutical ingredients (API) capabilities due to various incentives like cheap land and electricity. India may have to consider similar incentives to ensure domestic manufacturers build scale and compete with lower Chinese prices.

  • Niti Aayog, in a meeting on India’s dependence on imports of “critical” APIs, with the government had given some suggestions on environmental concerns and financial incentives like subsidies, which will be examined by the government.

About CDSCO:

The Central Drugs Standard Control Organisation (CDSCO) under Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India is the National Regulatory Authority (NRA) of India.

Functions: Under the Drugs and Cosmetics Act, CDSCO is responsible for approval of New Drugs, Conduct of Clinical Trials, laying down the standards for Drugs, control over the quality of imported Drugs in the country and coordination of the activities of State Drug Control Organizations by providing expert advice with a view to bring about the uniformity in the enforcement of the Drugs and Cosmetics Act.

CDSCO along with state regulators, is jointly responsible for grant of licenses of certain specialized categories of critical Drugs such as blood and blood products, I. V. Fluids, Vaccine and Sera.

Source: Indian Express


Pradhan Mantri Suryodaya Yojana

Recently, Prime Minister announced Pradhan Mantri Suryodaya Yojana under which 1 crore households will get rooftop solar power systems. India’s Status of Current Solar Capacity India currently stands at 4th place globally in solar power capacity. As per Ministry of New an

Foreign Contribution Regulation Act (FCRA)- NGO 

The Foreign Contribution Regulation Act, 2010 (FCRA) registration of two prominent non-governmental organisations (NGOs) — Centre for Policy Research (CPR) and World Vision India (WVI) have been cancelled this month. What is FCRA? Key provisions of FCRA, 2010 Key aspects Description

Voice clone-AI

Voice clone fraud has been on the rise in India. AI voice cloning – It is the process of creating a synthetic replica of a person’s voice through machine learning and speech synthesis technology.It is called as voice deepfakesor audio deepfakes. Objective – To achieve a high level of na

Science communication- how to promote

Steps taken by India to promote Science Communication Publications and Information Directorate (PID) - An organisation under Council of Science and Industrial Research (CSIR) established in 1951 for publishing and disseminating scientific information in India. National science magazines- The PI

Universal Basic Income (UBI)- Analysis

Universal Basic Income (UBI) can strengthen welfare architecture and unlock the nation’s latent demographic potential. UBI - It is an income support mechanism typically intended to reach all or a very large portion of the population regardless of their earnings or employment status. Objective- To provide enough to co

Toppers

Search By Date

Newsletter Subscription
SMS Alerts

Important Links

UPSC GS Mains Crash Course - RAW Prelims Answer Key 2024